Regorafenib inhibits ERK signaling and suppresses the growth of sorafenib-resistant cells in human hepatocellular carcinoma

被引：0
|
作者：
Hashiba, Tomomi [1 ]
Yamashita, Taro [1 ]
Okada, Hikari [1 ]
Nio, Kouki [1 ]
Hayashi, Takehiro [1 ]
Nomura, Yoshimoto [1 ]
Yoshida, Mariko [1 ]
Hayashi, Tomoyuki [1 ]
Oishi, Naoki [1 ]
Honda, Masao [1 ]
Kaneko, Shuichi [1 ]
机构：
[1] Kanazawa Univ, Grad Sch Med, Gastroenterol, Kanazawa, Ishikawa, Japan
来源：
HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1953
引用
收藏
页码：1160A / 1160A
页数：1
相关论文
共 50 条
  • [1] Regorafenib but not sorafenib suppresses ERK signaling in human hepatocellular carcinoma acquiring sorafenib resistance
    Hashiba, Tomomi
    Yamashita, Taro
    Okada, Hikari
    Hayashi, Takehiro
    Yoshida, Mariko
    Sunagozaka, Hajime
    Honda, Masao
    Kaneko, Shuichi
    HEPATOLOGY, 2016, 64 : 248A - 248A
  • [2] Fucoidan inhibits EGFR redistribution and potentiates sorafenib to overcome sorafenib-resistant hepatocellular carcinoma
    Luo, Jialiang
    Li, Lei
    Zhu, Zhengyumeng
    Chang, Bo
    Deng, Fan
    Wang, Di
    Lu, Xiao
    Zuo, Daming
    Chen, Qingyun
    Zhou, Jia
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 154
  • [3] Evaluating the Effect of Lenvatinib on Sorafenib-Resistant Hepatocellular Carcinoma Cells
    Shi, Tingting
    Iwama, Hisakazu
    Fujita, Koji
    Kobara, Hideki
    Nishiyama, Noriko
    Fujihara, Shintaro
    Goda, Yasuhiro
    Yoneyama, Hirohito
    Morishita, Asahiro
    Tani, Joji
    Yamada, Mari
    Nakahara, Mai
    Takuma, Kei
    Masaki, Tsutomu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (23)
  • [4] HBx Modulates Drug Resistance of Sorafenib-Resistant Hepatocellular Carcinoma Cells
    Liu, Yaping
    Liu, Xu
    Luo, Miaosha
    Li, Yarui
    Li, Hongxia
    DISCOVERY MEDICINE, 2023, 35 (179) : 1035 - 1042
  • [5] TIGAR Overexpression Increases Chemosensitivity in Sorafenib-resistant Hepatocellular Carcinoma Cells
    Derdak, Zoltan
    Harb, Ragheb
    Wands, Jack R.
    HEPATOLOGY, 2014, 60 : 811A - 811A
  • [6] Adjutant therapeutic strategy for sorafenib-resistant hepatocellular carcinoma
    Peng, Syue-Wei
    Lin, Yi-Heng
    Teng, Ming-Hao
    Lai, Hung-Cheng
    Chang, Te-Sheng
    Huang, Yen-Hua
    CANCER RESEARCH, 2018, 78 (13)
  • [7] Dietary antioxidant quercetin overcomes the acquired resistance of Sorafenib in Sorafenib-resistant hepatocellular carcinoma cells through epidermal growth factor receptor signaling inactivation
    Zhang, Zhengguang
    Wu, Haitao
    Zhang, Yajie
    Shen, Cunsi
    Zhou, Fuqiong
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (01) : 559 - 574
  • [8] Dietary antioxidant quercetin overcomes the acquired resistance of Sorafenib in Sorafenib-resistant hepatocellular carcinoma cells through epidermal growth factor receptor signaling inactivation
    Zhengguang Zhang
    Haitao Wu
    Yajie Zhang
    Cunsi Shen
    Fuqiong Zhou
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2024, 397 : 559 - 574
  • [9] Predictors of ribociclib-mediated antitumour effects in native and sorafenib-resistant human hepatocellular carcinoma cells
    Florian P. Reiter
    Gerald Denk
    Andreas Ziesch
    Andrea Ofner
    Ralf Wimmer
    Simon Hohenester
    Tobias S. Schiergens
    Matilde Spampatti
    Liangtao Ye
    Timo Itzel
    Stefan Munker
    Andreas Teufel
    Alexander L. Gerbes
    Julia Mayerle
    Enrico N. De Toni
    Cellular Oncology, 2019, 42 : 705 - 715
  • [10] Sorafenib-Resistant Hepatocellular Carcinoma Stratified by Phosphorylated ERK Activates PD-1 Immune Checkpoint
    Chen, Jiang
    Ji, Tong
    Zhao, Jie
    Li, Gaofeng
    Liang, Xiao
    Xie, Anyong
    Lin, Hui
    Cang, Yong
    Cai, Xiujun
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (01) : 152 - +
12345